Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers

计划入组 279 人 · 首次发布于 2016 年 9 月 8 日

A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers

计划入组 123 人 · 首次发布于 2018 年 2 月 27 日

A Trial of the Combination of SHR-A1811 and Fluzoparib in HER2-Expressing Cancers

计划入组 212 人 · 首次发布于 2022 年 4 月 27 日

Werner inhibitor (MSI-high cancers/sensitive cancers)

Kras Inhibitor (cancers)

Her2-DIDT

Zymeworks

Canada

ASSO DE RECHERCHE CANCERS GYNECOLOGIQUES

France

Nuvalent

United States

Cinrebafusp Alfa Shows Promise in HER2-Expressing Solid Tumors: A Phase I Study

Phrontline Biopharma's TJ106 Shows Promise Against HER2-Low and ADC-Resistant Tumors in Preclinical Studies

Radiopharm Theranostics' RAD 202 Receives Ethics Approval for Phase 1 Trial in HER2-Expressing Solid Tumors